TREA

88074194 - MONJUVI

Follow

Information

  • Trademark
  • 88074194
  • Serial Number
    88074194
  • Registration Number
    6031814
  • Filing Date
    August 10, 2018
    5 years ago
  • Registration Date
    April 14, 2020
    4 years ago
  • Transaction Date
    May 02, 2024
    21 days ago
  • Status Date
    April 14, 2020
    4 years ago
  • Published for Opposition Date
    July 16, 2019
    4 years ago
  • Location Date
    April 14, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    INGOLD, GERALDINE
  • Attorney Docket Number
    114353.00048
    Attorney Name
    Michael J. Leonard
    Law Office Assigned Location Code
    N30
  • Owners
Information
Mark Drawing Code
4
Mark Identification
MONJUVI
Case File Statements
  • GS0051: Pharmaceuticals and pharmaceutical preparations for human and veterinary use for the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; vaccine preparations; vaccines; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines for use in the treatment and prevention of metabolic disorders, cancer, inflammatory diseases, and restenosis; diagnostic preparations for medical or veterinary purposes; biological preparations for human medical diagnostics and analysis for the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; biological preparations for medical and veterinary purposes for use in the treatment of metabolic disorders, cancer, inflammatory diseases, and restenosis; none of the foregoing goods for use in connection with the treatment or prevention of ear disorders
  • GS0421: Research and development in the pharmaceutical and biotechnology fields; research and development of vaccines and medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies
Case File Event Statements
  • 11/20/2018 - 5 years ago
    7 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 8/14/2018 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 8/20/2018 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/9/2018 - 5 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 9/18/2018 - 5 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 9/18/2018 - 5 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 11/15/2018 - 5 years ago
    6 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 11/28/2018 - 5 years ago
    8 - ASSIGNED TO EXAMINER Type: DOCK
  • 12/4/2018 - 5 years ago
    9 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/4/2018 - 5 years ago
    10 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/4/2018 - 5 years ago
    11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/31/2019 - 4 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/31/2019 - 4 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/1/2019 - 4 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/10/2019 - 4 years ago
    16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/10/2019 - 4 years ago
    17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/10/2019 - 4 years ago
    15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 7/16/2019 - 4 years ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/10/2019 - 4 years ago
    18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/12/2019 - 4 years ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/26/2019 - 4 years ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/16/2019 - 4 years ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/22/2019 - 4 years ago
    23 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 10/22/2019 - 4 years ago
    24 - TEAS POST PUBLICATION AMENDMENT RECEIVED Type: EPPA
  • 11/18/2019 - 4 years ago
    25 - ASSIGNED TO PETITION STAFF Type: APET
  • 11/20/2019 - 4 years ago
    26 - CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED Type: CHPB
  • 1/13/2020 - 4 years ago
    27 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 3/7/2020 - 4 years ago
    29 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 3/7/2020 - 4 years ago
    30 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 3/7/2020 - 4 years ago
    28 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 4/24/2024 - 29 days ago
    32 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Type: ASCK
  • 5/1/2024 - 22 days ago
    33 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 4/14/2020 - 4 years ago
    31 - REGISTERED-PRINCIPAL REGISTER Type: R.PR